Skip to main content
. 2019 Jul 24;10(7):247–255. doi: 10.5306/wjco.v10.i7.247

Figure 3.

Figure 3

Tumor biopsy before and after treatment with nivolumab. A: Pretreatment tumor biopsy in 2012, HE-stain. Note the intratumoral lymphocytes (TILS); B: Posttreatment tumor biopsy of the high-grade serous carcinoma of the left colic flexure in 2016, HE-stain. Note reduced intratumoral lymphocytes.